Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome

被引:10
作者
Ajossa, S [1 ]
Guerriero, S [1 ]
Paoletti, AM [1 ]
Orrù, M [1 ]
Melis, GB [1 ]
机构
[1] Univ Cagliari, Dept Obstet & Gynecol, Cagliari, Italy
关键词
androgens; C-peptide; DHEAS; insulin; PCOS; uterine perfusion;
D O I
10.1046/j.1469-0705.2002.00790.x
中图分类号
O42 [声学];
学科分类号
070206 [声学]; 082403 [水声工程];
摘要
Objective To determine whether hyperinsulinemia has a negative effect on uterine blood supply in patients with polycystic ovary syndrome (PCOS). Methods Sixty-three patients with normal body mass index were included prospectively in the study: 48 had clinical and hormonal features of PCOS and 15 were normo-ovulatory. All patients underwent Doppler flow measurement of the uterine artery, and determination of serum concentrations of luteinizing hormone, follicle stimulating hormone, prolactin, estradiol, androgens, insulin and C-peptide during the early follicular phase of the menstrual cycle. The 48 PCOS-patients were divided into two groups according to the pulsatility index (PI) value of the uterine artery: Group 1, PI < 3; Group 2, PI greater than or equal to 3 and the groups were compared. Results The mean PI of the uterine artery (3.01 +/- 1.0 vs. 1.93 +/- 0.3, respectively) and fasting levels of insulin (50.9 +/- 9.3 vs. 40.3 +/- 10.9) and C-peptide (366.9 +/- 118.4 vs. 243.6 +/- 120.3) of PCOS-patients were significantly higher than those of the control group. No correlation was found between insulinemia and C-peptide and PI of the uterine artery and no significant difference was found in insulin and C-peptide levels among the two groups of PCOS-affected patients. Only the serum level of dehydroepiandrosterone sulfate was significantly higher in Group 2, and a direct correlation was found between PI values of the uterine artery and DHEAS plasma levels. Conclulsion Insulin and C-peptide do not seem to interfere with uterine perfusion in PCOS-affected patients.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 32 条
[1]
Effect of chronic administration of cabergoline on uterine perfusion in women with polycystic ovary syndrome [J].
Ajossa, S ;
Paoletti, AM ;
Guerriero, S ;
Floris, S ;
Mannias, M ;
Melis, GB .
FERTILITY AND STERILITY, 1999, 71 (02) :314-318
[2]
Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome [J].
Ajossa, S ;
Guerriero, S ;
Paoletti, AM ;
Orrù, M ;
Floris, S ;
Mannias, M ;
Melis, GB .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2001, 18 (08) :436-440
[3]
INSULIN STIMULATES ANDROGEN ACCUMULATION IN INCUBATIONS OF OVARIAN STROMA OBTAINED FROM WOMEN WITH HYPERANDROGENISM [J].
BARBIERI, RL ;
MAKRIS, A ;
RANDALL, RW ;
DANIELS, G ;
KISTNER, RW ;
RYAN, KJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :904-910
[4]
THE ROLE OF COLOR DOPPLER IMAGING IN THE DIAGNOSIS OF POLYCYSTIC-OVARY-SYNDROME [J].
BATTAGLIA, C ;
ARTINI, PG ;
DAMBROGIO, G ;
GENAZZANI, AD ;
GENAZZANI, AR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (01) :108-113
[5]
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome [J].
Battaglia, C ;
Artini, PG ;
Genazzani, AD ;
Gremigni, R ;
Salvatori, M ;
Sgherzi, MR ;
Giulini, S ;
Lombardo, M ;
Volpe, A .
GYNECOLOGICAL ENDOCRINOLOGY, 1997, 11 (02) :105-110
[6]
Color Doppler analysis in lean and obese women with polycystic ovary syndrome [J].
Battaglia, C ;
Artini, PG ;
Genazzani, AD ;
Sgherzi, MR ;
Salvatori, M ;
Giulini, S ;
Volpe, A .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1996, 7 (05) :342-346
[7]
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism [J].
Cagnacci, A ;
Paoletti, AM ;
Arangino, S ;
Melis, GB ;
Volpe, A .
HUMAN REPRODUCTION, 1999, 14 (04) :893-897
[8]
CUSAN L, 1994, FERTIL STERIL, V61, P281
[9]
DEZIEGLER D, 1991, FERTIL STERIL, V55, P775
[10]
INSULIN SENSITIVITY AND ANTIANDROGENIC THERAPY IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME [J].
DIAMANTIKANDARAKIS, E ;
MITRAKOU, A ;
HENNES, MMI ;
PLATANISSIOTIS, D ;
KAKLAS, N ;
SPINA, J ;
GEORGIADOU, E ;
HOFFMANN, RG ;
KISSEBAH, AH ;
RAPTIS, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (04) :525-531